GUIDED THERAPEUTICS INC Total Assets

Quick Answer

GUIDED THERAPEUTICS INC reported Total Assets of $1.32 million for the year ending 2025.

  • GUIDED THERAPEUTICS INC showed a decrease of -3.9% in Total Assets from 2024 to 2025.
  • This data is from GUIDED THERAPEUTICS INC's annual report (Form 10-K), filed with the SEC on March 31, 2026.
  • XBRL data for this metric is available from 2010 to 2025 (16 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Quarterly values from 10-Q filings: Q4 2010: $3.92 million | Q2 2011: $3.32 million | Q1 2012: $3.09 million | Q3 2012: $4.77 million | Q1 2013: $3.59 million | Q2 2013: $4.40 million | Q3 2013: $2.93 million | Q1 2014: $2.60 million | Q2 2014: $3.82 million | Q3 2014: $3.72 million | Q1 2015: $2.56 million | Q2 2015: $4.04 million | Q3 2015: $2.77 million | Q1 2016: $2.37 million | Q2 2016: $2.31 million | Q3 2016: $2.06 million | Q1 2017: $1.49 million | Q2 2017: $1.51 million | Q3 2017: $905.0 thousand | Q1 2018: $527.0 thousand | Q2 2018: $418.0 thousand | Q3 2018: $491.0 thousand | Q1 2019: $404.0 thousand | Q2 2019: $260.0 thousand | Q3 2019: $339.0 thousand | Q1 2020: $364.0 thousand | Q2 2020: $942.0 thousand | Q1 2021: $2.36 million | Q2 2021: $2.07 million | Q3 2021: $1.74 million | Q1 2022: $2.19 million | Q2 2022: $1.50 million | Q3 2022: $3.87 million | Q1 2023: $2.89 million | Q2 2023: $2.35 million | Q3 2023: $1.88 million | Q1 2024: $1.49 million | Q2 2024: $1.25 million | Q3 2024: $1.25 million | Q1 2025: $967.0 thousand | Q2 2025: $940.0 thousand | Q3 2025: $903.0 thousand.
  • Over the full 16 years of available data (2010 to 2025), GUIDED THERAPEUTICS INC's Total Assets has declined by 66.2%.
  • Historical annual values: Fiscal year 2025: $1.32 million | Fiscal year 2024: $1.38 million | Fiscal year 2023: $1.67 million | Fiscal year 2022: $3.37 million | Fiscal year 2021: $2.04 million | Fiscal year 2020: $1.35 million | Fiscal year 2019: $1.18 million | Fiscal year 2018: $236.0 thousand | Fiscal year 2017: $406.0 thousand | Fiscal year 2016: $1.49 million | Fiscal year 2015: $2.52 million | Fiscal year 2014: $3.03 million | Fiscal year 2013: $3.32 million | Fiscal year 2012: $3.48 million | Fiscal year 2011: $4.31 million | Fiscal year 2010: $3.92 million.
  • Data sourced from SEC EDGAR public filings as of August 5, 2026.

Last verified: